Lenvatinib with or without immune checkpoint inhibitors for patients with unresectable hepatocellular carcinoma in real-world clinical practice

作者：Kang Chen, Wei Wei, Lei Liu, Zhu‐Jian Deng, Le Li, Xiumei Liang, Pingping Guo, Lu‐Nan Qi, Zhiming Zhang, Wen‐Feng Gong, Shan Huang, Weiping Yuan, Liang Ma, Bang‐De Xiang, Le‐Qun Li, Jian‐Hong Zhong · 发表于：Cancer Immunology Immunotherapy · 年份：2021 · DOI：10.1007/s00262-021-03060-w · 被引用次数：39 · 研究领域：Hepatocellular Carcinoma Treatment and Prognosis、Cholangiocarcinoma and Gallbladder Cancer Studies、Cancer Mechanisms and Therapy